London
giles.parsons@brownejacobson.com
+44 (0)20 7337 1505
Giles has helped protect world leading brands, manages significant IP portfolios and negotiates high-value R&D agreements. Giles is a member of the Law Society’s IP Committee. Over 30 articles of his have been published by Lexis Nexis, Practical Law and various IP journals. Giles is also a trustee of the Diversity Project Charity.
Giles was a Euromoney 2020 Rising Star Awards winner in the trade marks category. He is also ranked as a Next Generation Partner for Intellectual Property: trade marks, copyright and Designs in Legal 500. World Trademark Review has said that Giles “consistently does a first-class job – he wins cases” and that he is “a pleasure to work with”.
Giles’ contentious experience includes acting for some of the world’s most famous brands in the IPEC, the Chancery Division, the Court of Appeal and the EU General Court. He helps clients with technology development agreements, trade mark licences, sponsorship and influencer agreements, and collaboration agreements. He also helps manage IP portfolios for leading technology companies and brands.
Helping Match and Tinder successfully protect their brand in the UK Intellectual Property Enterprise Court.
Supporting an automotive OEM launch exciting new models with next generation technology.
Helping Iconic London grow and expand into new markets.
Built and implemented a monitoring and enforcement strategy for a well-known cosmetics client.
"Giles Parsons has a great intellect and knowledge of case law, as well as the ability to grapple with the most complex matters, rapidly absorbing the information and providing clients with a reasoned way forward. There is no technology he cannot understand and advise on."
Parsons dedicates time and energy to both the management of extensive IP portfolios and the negotiation of high-rolling R&D agreements. He is reportedly "very good at dealing with tricky opponents without ever losing his cool".
"Giles Parsons is a key contact in the firm, particularly for automotive clients."
“Cool-hand litigator” Giles Parsons is “highly pragmatic in his advice, responsive and a pleasure to work with.”
Every AI will have its own terms of use. DALL·E 2’s Terms of Use dated 3 November 2022 specify that as between a user and Open AI, a user owns their prompts and uploads. Open AI also assigns to the user all rights in any images generated by DALL·E 2 for that user (subject to the user complying with those Terms of Use, and to a licence to use inputs and output to develop and improve the services).
National law firm Browne Jacobson has been ranked again for both its patent litigation and transactional work in the 2022 edition of IAM Patent 1000, the independent guide to the world’s leading patent law firms and practitioners.
Browne Jacobson’s national IP lawyers are celebrating after being ranked in the 2022 World Trademark Review (WTR) 1000 - the independent guide which recognises leading trade mark experts across key jurisdictions around the globe.
We invite you to watch our on-demand webinar which looks into how healthtech is commissioned from a health and tech perspective.
Browne Jacobson’s national IP team is celebrating after again securing Tier 1 rankings in the East and West Midlands region and maintaining its Tier 3 status in London in the latest edition of Legal 500.
The EU has published a redacted version of its contract with UK drug maker AstraZeneca to procure the Covid-19 vaccine.
Covid-19 and the challenges associated with it grind on into a second wave. Not only that but there’s the prospect of Brexit and a looming recession ahead. It would be entirely forgivable not to be on top of the law right now. Watch our on-demand video, where we have discussed Brexit and intellectual property and consumer and commercial law changes.
Parallel importers seek to exploit price differentials for goods sold in different countries. The EU principle of exhaustion of rights prevents businesses from enforcing their IP rights to restrict this secondary trade within the EU if the goods were first marketed in the EU with their consent, other than in limited circumstances.
